No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
412 |
4. Check minimum number of eventsNone |
412 |
5. Include endpointsNone |
412 |
6. Filter based on genotype QC (FinnGen only) |
373 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF6
- Parent code in ICD-10
- M71
- Name in latin
- Alia bursitis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Other bursitis, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other bursopathies
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2968 | 1448 | 1495 |
| Only index persons | 2403 | 1236 | 1167 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 50.46 | 52.17 | 48.69 |
| Only index persons | 47.55 | 49.66 | 45.32 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 373 | 200 | 173 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.08 |
| Median age at first event (years) | 50.95 | 50.83 | 51.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 387
- Matched controls
- 3870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M71.5
ICD-10 Finland
Other bursitis, not elsewhere classified
3071.0
283.3
239
*
7273A
ICD-9 Finland
Other disorders of synovium, tendon and bursa, Other bursitis
+∞
167.1
148
*
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
292.7
51.4
51
*
M76.6
ICD-10 Finland
Achilles tendinitis
10.6
45.5
53
57
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.6
38.7
118
337
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
15.1
35.2
32
23
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
+∞
34.9
33
*
M79.6
ICD-10 Finland
Pain in limb
3.6
34.3
195
849
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
27.2
209
1052
M67.4
ICD-10 Finland
Ganglion
8.1
25.0
35
47
M19.0
ICD-10 Finland
Primary arthrosis of other joints
5.0
23.3
55
125
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
48.1
22.7
27
6
M25.5
ICD-10 Finland
Pain in joint
3.0
22.5
148
668
N03AX16
ATC
[U] pregabalin
3.1
20.2
107
425
M79.0
ICD-10 Finland
Rheumatism, unspecified
60.9
20.1
23
*
N02AX02
ATC
tramadol; systemic, rectal
2.7
19.9
189
1019
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
16.2
18.8
30
20
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
18.7
185
1010
M70.6
ICD-10 Finland
Trochanteric bursitis
3.8
18.6
63
188
M54.4
ICD-10 Finland
Lumbago with sciatica
3.1
17.3
84
314
NBG10
NOMESCO Finland
Acromioplastia
36.9
16.8
21
6
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.8
16.3
101
432
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
7.0
15.9
25
38
H02AB06
ATC
prednisolone; systemic
2.4
15.8
205
1238
M01AH05
ATC
etoricoxib; oral
2.4
15.4
254
1698
M77.4
ICD-10 Finland
Metatarsalgia
5.4
15.3
31
61
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
21.1
15.3
22
11
M01AX17
ATC
nimesulide; oral
2.6
15.2
110
508
M02AA07
ATC
piroxicam; topical
2.4
14.9
151
813
R06.0
ICD-10 Finland
Dyspnoea
2.5
14.5
121
595
M79.1
ICD-10 Finland
Myalgia
3.3
14.3
61
210
M48.0
ICD-10 Finland
Spinal stenosis
3.2
13.9
60
208
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.7
13.6
33
76
M01AH01
ATC
celecoxib; oral
2.7
12.9
81
346
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.6
12.8
45
137
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
12.5
81
351
L08
ICPC
Shoulder symptom/complaint
2.5
12.4
91
418
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.5
12.4
46
145
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.7
12.2
40
116
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
5.5
12.2
24
46
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
14.0
12.1
20
15
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
12.0
80
351
M13.9
ICD-10 Finland
Arthritis, unspecified
3.9
12.0
36
98
A02BC02
ATC
pantoprazole; systemic
2.2
11.7
271
1979
S18
ICPC
Laceration/cut
2.1
11.7
195
1256
J01DA09
ATC
[U] cefadroxil
2.3
11.7
118
624
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
67.0
11.7
13
*
L03
ICPC
Low back symptom/complaint
2.3
11.6
113
589
Z50.1
ICD-10 Finland
Other physical therapy
4.4
11.6
30
73
N02BF01
ATC
gabapentin; oral
3.4
11.4
44
142
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.0
11.3
54
198
M03BX02
ATC
tizanidine; oral
2.1
11.0
238
1676
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.8
10.9
34
95
L15
ICPC
Knee symptom/complaint
2.3
10.9
105
543
M54.5
ICD-10 Finland
Low back pain
2.1
10.6
134
771
R52.9
ICD-10 Finland
Pain, unspecified
3.0
10.5
50
183
N03AX12
ATC
[U] gabapentin; oral
2.7
10.4
63
262
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.6
10.4
68
294
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
10.3
98
503
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
10.2
44
152
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
10.2
57
228
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
10.0
79
373
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.8
10.0
55
218
M01AC06
ATC
meloxicam; systemic, rectal
2.1
10.0
142
851
L88
ICPC
Rheumatoid/seropositive arthritis
4.7
9.9
23
51
L17
ICPC
Foot/toe symptom/complaint
2.1
9.8
116
649
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
9.6
44
157
M01AB05
ATC
diclofenac; systemic, rectal
2.0
9.6
256
1902
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
4.1
9.6
27
70
N06AX21
ATC
duloxetine; oral
2.9
9.3
46
172
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
9.2
80
393
M02AA10
ATC
ketoprofen; topical
2.5
9.2
65
291
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
9.1
50
198
L04AX03
ATC
methotrexate; systemic
2.8
9.0
46
175
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
9.0
112
636
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
8.8
133
809
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
3.0
8.7
41
149
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
8.7
186
1268
L01BA01
ATC
methotrexate; systemic
4.9
8.7
19
40
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
8.6
103
575
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
4.1
8.6
24
62
1220
FHL
Arthroscopy
4.5
8.5
21
49
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
8.5
42
157
H02AB04
ATC
methylprednisolone; systemic
2.4
8.4
62
283
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.5
8.4
29
87
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
8.2
179
1223
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.5
8.1
57
254
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
12.1
8.1
14
12
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
34.1
8.1
10
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.9
8.0
24
65
M10.9
ICD-10 Finland
Gout, unspecified
3.2
8.0
33
111
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.6
7.9
48
200
R60.0
ICD-10 Finland
Localized oedema
2.5
7.9
53
232
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
7.8
85
457
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
45.9
7.7
9
*
B01AB05
ATC
enoxaparin; parenteral
1.9
7.7
124
765
M01AH02
ATC
rofecoxib; oral
2.5
7.6
51
222
M71.9
ICD-10 Finland
Bursopathy, unspecified
18.8
7.6
11
6
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
7.6
54
242
P01BA02
ATC
hydroxychloroquine; oral
3.0
7.6
34
120
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.1
7.5
21
54
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
3.4
7.5
27
83
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
7.4
45
187
ZXA00
NOMESCO Finland
Right side
2.0
7.4
102
595
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.5
7.4
25
74
E66.8
ICD-10 Finland
Other obesity
3.5
7.4
25
74
J01AA02
ATC
doxycycline; systemic
2.0
7.4
298
2432
TQW40
NOMESCO Finland
Remowal of suture of skin
3.1
7.4
32
111
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
7.3
194
1390
J01FF01
ATC
clindamycin; systemic
2.0
7.3
104
613
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
7.3
138
893
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
16.1
7.3
11
7
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
7.2
55
254
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
2.5
7.2
49
215
M70.2
ICD-10 Finland
Olecranon bursitis
6.8
7.2
17
26
WX320
NOMESCO Finland
Spinalanesthesy
2.0
7.2
95
546
M70.8
ICD-10 Finland
Other soft tissue disorders related to use, overuse and pressure
20.5
7.2
10
5
ZXA05
NOMESCO Finland
Left side
2.0
7.1
91
516
NB1AD
NOMESCO Finland
Shoulder CT examination
9.0
7.1
14
16
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.6
7.1
23
66
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.8
7.0
21
57
A02BC05
ATC
esomeprazole; systemic
1.8
7.0
151
1015
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.7
7.0
22
62
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.9
6.9
20
53
M75.2
ICD-10 Finland
Bicipital tendinitis
9.6
6.8
13
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
6.7
72
382
L84
ICD-10 Finland
Corns and callosities
4.1
6.7
18
45
M79.7
ICD-10 Finland
Fibromyalgia
12.5
6.6
11
9
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
8.9
6.6
13
15
M01AE02
ATC
naproxen; oral, rectal
1.7
6.6
205
1524
L13
ICPC
Hip symptom/complaint
2.1
6.4
68
360
SPAT1153
SPAT
Removal of sutures
1.8
6.3
114
722
J01CA04
ATC
amoxicillin; systemic
1.9
6.3
301
2513
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
18.4
6.3
9
5
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
+∞
6.3
6
*
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
27.2
6.2
8
*
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.9
6.2
18
48
R05
ICPC
Cough
1.9
6.1
92
549
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
3.7
6.1
19
53
R03AC02
ATC
salbutamol; inhalant
1.7
6.1
200
1496
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
3.6
6.1
20
58
A11
ICPC
Chest pain NOS
2.6
6.1
37
154
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
3.1
6.1
25
84
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.3
6.0
45
206
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
121
618
2.39
13.21
1.8
1.5
1.08
1.37
mg/l
0.38
97
485
97
472
2.41
11.64
1.3
1.2
6.44
15.56
u/ml
1.27
34
179
102
520
2.31
10.94
1.3
1.2
86.91
36.89
iu/ml
0.55
30
171
288
2243
2.11
9.34
5.9
3.9
11.98
12.52
mm/h
0.30
270
2077
25
66
3.98
8.66
1.7
1.3
—
—
—
0
0
206
1463
1.87
8.37
3.2
2.8
—
—
estimate
—
0
0
40
171
2.49
6.22
1.7
1.7
—
—
—
0
0
50
244
2.20
5.77
3.9
2.7
67.19
62.90
ml/min/173m2
0.38
21
105
228
1784
1.68
5.72
10.3
10.4
4.25
4.17
e9/l
0.19
201
1556
136
931
1.71
5.66
2.1
2.1
154.91
198.48
u/l
0.82
130
875
197
1493
1.65
5.52
13.3
13.4
1.18
1.25
inr
1.28
174
1221
24
84
2.98
5.46
1.2
1.3
—
—
—
0
0
118
793
1.70
5.19
2.1
2.1
2.93
3.07
mg/l
0.19
103
689
79
473
1.84
5.16
2.2
2.6
2.35
2.29
g/l
0.32
72
440
162
1192
1.62
4.96
3.8
3.6
40.89
37.58
ng/l
0.08
107
859
20
68
3.05
4.79
1.6
1.5
12555.93
14587.82
e6/l
0.09
15
50
72
437
1.80
4.47
2.4
2.6
23.37
22.34
%
0.19
67
412
181
1401
1.55
4.28
5.1
6.5
1.21
1.21
mmol/l
0.01
165
1294
110
759
1.63
4.26
2.7
2.9
344.55
350.43
umol/l
0.22
98
675
130
937
1.58
4.19
3.1
3.2
944.82
1561.48
ng/l
2.43
111
806
110
775
1.59
3.87
2.8
2.4
—
—
—
0
0
17
63
2.78
3.54
1.1
1.2
—
—
—
0
0
19
75
2.61
3.52
1.2
1.5
—
—
—
0
0
193
1561
1.47
3.46
6.4
7.3
1.21
1.21
mmol/l
0.01
168
1344
174
1384
1.47
3.38
2.6
2.3
72.98
77.11
nmol/l
1.17
153
1249
180
1456
1.44
3.13
3.1
2.8
115.20
136.49
ug/l
0.88
167
1360
277
2430
1.49
3.12
5.0
3.9
14.77
14.80
pmol/l
0.06
249
2220
337
3096
1.69
3.01
21.5
14.7
20.81
25.46
mg/l
1.98
292
2508
39
224
1.82
2.91
3.0
3.2
347.56
196.28
ng/l
0.86
39
201
23
111
2.14
2.79
2.2
1.9
—
—
—
0
0
196
1635
1.40
2.75
3.9
3.4
0.00
0.01
estimate
0.50
36
307
27
140
2.00
2.73
1.3
1.6
1.74
1.52
g/l
0.64
22
130
192
1602
1.39
2.67
4.0
3.5
0.00
0.00
estimate
-0.00
40
329
273
2420
1.43
2.66
10.0
8.1
78.02
80.04
u/l
0.35
261
2304
24
121
2.05
2.62
2.2
2.0
—
—
—
0
0
193
1618
1.38
2.58
3.9
3.5
0.00
0.00
estimate
-0.00
40
333
71
495
1.53
2.56
1.6
1.7
1125.73
1165.72
nmol/l
0.11
49
377
10
32
3.18
2.45
1.1
1.1
—
—
—
0
0
8
22
3.69
2.37
1.3
1.1
—
—
—
0
0
211
1818
1.35
2.27
3.3
2.8
—
—
—
0
0
5
9
5.61
2.22
1.6
1.3
—
—
—
0
0
90
678
1.43
2.20
1.3
1.2
2.99
2.11
u/ml
0.18
21
187
72
520
1.47
2.19
2.1
1.9
—
—
—
0
0
82
608
1.44
2.18
4.7
3.6
126.28
463.54
ng/l
1.47
71
485
21
110
1.96
2.10
1.9
1.6
6.85
5.43
u/ml
—
6
25
18
89
2.07
2.09
2.2
1.5
—
—
—
0
0
123
985
1.36
2.09
3.1
2.3
51.92
69.10
u/l
1.56
110
919
25
140
1.84
2.06
3.4
5.0
1.65
1.64
%
0.04
25
130
164
1379
1.33
2.00
2.2
2.0
97.51
93.92
pmol/l
0.43
79
740
196
1695
1.32
1.94
7.1
6.8
10.30
11.72
umol/l
1.80
181
1624
314
2912
1.42
1.93
6.2
4.8
1.73
1.94
mu/l
3.30
296
2674
13
58
2.28
1.93
1.2
1.2
—
—
—
0
0
36
231
1.62
1.87
1.4
1.5
—
—
—
0
0
88
679
1.38
1.86
3.8
3.7
1.02
1.02
kg/l
0.04
69
451
26
154
1.74
1.81
1.4
1.4
—
—
—
0
0
7
23
3.08
1.80
1.1
1.2
—
—
—
0
0
13
60
2.21
1.79
1.7
1.4
—
—
—
0
0
54
388
1.46
1.70
4.2
4.8
33.53
31.42
%
0.62
36
252
38
254
1.55
1.68
2.3
2.4
2.69
8.94
ug/l
3.55
27
221
6
19
3.19
1.66
1.3
1.1
0.10
1.19
u/ml
—
6
8
343
3253
1.48
1.66
22.6
17.5
4.02
3.97
mmol/l
2.36
332
3169
63
469
1.41
1.64
1.4
1.4
—
—
—
0
0
342
3245
1.46
1.62
22.3
17.2
139.84
139.73
mmol/l
0.40
334
3168
5
14
3.60
1.62
2.0
1.7
36.74
67.92
ug/l
—
5
14
8
32
2.53
1.60
1.4
1.5
—
—
—
0
0
8
32
2.53
1.60
1.4
1.5
—
—
—
0
0
144
1219
1.29
1.60
3.9
3.5
0.00
0.03
estimate
0.79
32
277
27
168
1.65
1.60
4.2
3.3
2.30
1.89
mmol/l
0.30
21
127
6
20
3.03
1.58
1.2
1.9
81.33
122.65
ng/l
—
6
20
131
1097
1.29
1.58
2.6
3.7
2.33
2.36
mmol/l
1.39
115
1003
321
3017
1.38
1.57
6.3
6.2
39.26
39.29
mmol/mol
0.02
304
2824
49
352
1.45
1.55
3.4
2.7
6.00
8.40
umol/l
1.00
41
317
8
33
2.45
1.54
1.4
1.5
—
—
—
0
0
165
1429
1.27
1.51
5.2
4.9
35.50
35.75
g/l
0.24
158
1352
32
212
1.56
1.49
2.1
1.7
—
—
—
0
0
16
87
1.88
1.48
1.4
1.2
—
—
—
0
0
9
40
2.28
1.41
1.2
1.4
—
—
—
0
0
15
83
1.84
1.33
1.1
1.5
—
—
—
0
0
58
444
1.36
1.30
3.5
6.7
104.52
104.56
mmol/l
0.03
58
444
107
893
1.27
1.30
1.8
1.6
19.58
19.73
nmol/l
0.04
89
753
8
34
2.38
1.30
1.3
1.5
—
—
—
0
0
40
288
1.43
1.28
2.1
2.4
0.22
0.21
g/l
0.46
32
271
8
35
2.31
1.27
1.4
1.5
—
—
—
0
0
8
35
2.31
1.27
1.4
1.5
—
—
—
0
0
22
139
1.62
1.26
2.1
1.9
0.58
1.09
ug/l
0.59
16
115
49
367
1.38
1.26
4.9
7.9
0.53
1.12
mmol/l
0.82
42
302
6
25
2.42
1.25
1.0
1.4
2.07
1.02
promille
—
6
20
25
164
1.56
1.24
1.3
1.3
—
33.09
—
0
9
16
93
1.75
1.23
4.5
3.6
1.16
1.78
ratio
—
8
57
28
190
1.51
1.20
6.1
9.7
15.91
15.90
%
0.01
28
182
156
1372
1.23
1.19
1.9
1.9
1.36
1.34
mmol/l
0.12
128
1162
127
1094
1.24
1.17
3.0
3.3
7.61
7.77
mmol/l
0.16
106
928
13
72
1.83
1.16
4.2
2.0
0.00
0.00
g/l
-0.00
13
67
236
2171
1.22
1.14
3.9
3.2
55.21
50.81
u/l
0.30
225
2057
124
1069
1.24
1.13
3.6
4.1
7.93
9.34
mg/mmol
0.15
78
664
7
30
2.36
1.13
1.6
2.0
0.46
1.04
mmol/l
—
7
30
5
21
2.40
1.09
1.0
1.2
148.30
169.30
pmol/l
—
5
21
348
3354
1.37
1.08
14.8
11.4
25.26
26.01
u/l
0.49
338
3260
53
413
1.33
1.08
4.1
6.2
1.04
1.04
mmol/l
0.02
47
387
351
3388
1.39
1.08
25.6
19.2
78.56
78.23
umol/l
0.07
346
3344
107
913
1.24
1.07
3.3
2.9
0.00
0.02
estimate
0.99
35
252
12
69
1.76
0.97
1.2
1.2
20.35
37.18
u/l
0.45
12
61
16
102
1.59
0.92
2.4
2.5
—
—
—
0
0
13
79
1.67
0.89
2.7
2.9
2.25
2.62
index
—
8
45
101
874
1.21
0.88
4.3
3.6
0.00
0.01
estimate
0.50
38
310
66
546
1.25
0.87
3.3
2.7
0.73
0.97
e6/l
0.56
38
296
32
240
1.36
0.85
2.4
3.9
1.22
1.23
mmol/l
0.43
25
209
120
1065
1.18
0.79
3.2
3.3
35.63
33.05
u/l
0.19
110
1017
40
315
1.30
0.79
4.9
8.4
123.73
121.84
g/l
0.22
40
309
0
26
0.00
0.78
0.0
1.2
—
9.62
—
0
26
63
526
1.24
0.78
3.5
3.5
0.81
0.82
mmol/l
0.41
58
502
318
3062
1.22
0.75
18.6
14.4
80.96
80.55
ml/min/173m2
0.14
296
2837
77
662
1.20
0.72
1.6
1.8
445.19
20781944.05
pmol/l
0.50
58
563
45
365
1.26
0.72
1.9
1.9
—
—
—
0
0
7
40
1.76
0.71
5.4
1.8
—
—
—
0
0
47
384
1.25
0.71
2.0
1.8
—
—
—
0
0
19
135
1.43
0.70
1.1
1.0
—
—
—
0
0
5
28
1.80
0.66
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
95
1.49
0.65
1.6
2.6
0.30
0.36
iu/ml
—
9
47
99
880
1.17
0.64
3.7
2.9
0.34
0.56
e6/l
0.67
77
653
5
29
1.73
0.64
1.0
1.1
158.20
116.28
pmol/l
—
5
29
8
51
1.58
0.61
1.0
1.2
—
—
—
0
0
8
51
1.58
0.61
1.0
1.2
—
—
—
0
0
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
22
170
1.31
0.52
1.5
3.0
13.32
65.92
u/ml
1.98
22
162
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
121
1110
1.13
0.51
3.6
3.1
—
—
—
0
0
61
691
0.86
0.47
3.2
3.1
0.67
0.80
ug/l
0.86
40
439
29
237
1.24
0.47
1.9
1.8
3.46
3.48
mmol/l
0.04
23
176
124
1145
1.12
0.46
5.6
5.3
1.98
2.76
ug/l
1.01
114
1032
13
94
1.40
0.46
1.2
1.3
—
—
—
0
0
25
201
1.26
0.46
4.4
6.5
25.00
24.32
mmol/l
0.62
25
191
326
3181
1.16
0.46
5.4
5.0
4.55
4.64
mmol/l
0.91
306
2972
14
103
1.37
0.46
2.7
1.6
—
—
—
0
0
16
121
1.34
0.45
1.6
2.0
—
—
—
0
0
18
143
1.27
0.37
1.5
1.6
0.42
0.31
mg/l
—
8
69
57
509
1.14
0.37
3.8
2.8
2.08
2.43
e6/l
0.18
29
259
50
444
1.14
0.35
1.4
1.5
—
—
—
0
0
352
3467
1.17
0.35
31.4
22.5
254.97
248.22
e9/l
1.08
344
3395
311
3043
1.11
0.33
4.5
4.2
1.28
1.28
mmol/l
0.03
286
2805
33
380
0.86
0.33
3.8
4.8
12.83
39.72
ug/l
0.62
28
314
352
3469
1.16
0.33
31.3
22.5
4.45
4.50
e12/l
1.06
343
3387
16
128
1.26
0.32
1.1
1.3
21.78
29.34
iu/l
0.36
11
114
12
93
1.30
0.30
1.7
1.4
128.43
225.73
miu/ml
—
6
45
18
148
1.23
0.29
2.3
2.0
—
—
—
0
0
8
63
1.28
0.28
1.0
1.2
—
29.42
—
0
11
328
3229
1.10
0.26
6.2
5.7
2.65
2.72
mmol/l
0.66
305
3001
38
340
1.13
0.25
5.8
7.0
—
—
—
0
0
9
76
1.19
0.25
1.7
1.5
—
—
—
0
0
9
76
1.19
0.25
1.6
1.5
—
—
—
0
0
322
3172
1.09
0.23
5.5
4.9
1.43
1.46
mmol/l
0.69
301
2941
314
3091
1.08
0.22
5.3
4.9
5.84
5.95
mmol/l
0.96
291
2837
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
8.22
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
13
108
1.21
0.20
1.5
1.5
—
—
—
0
0
6
49
1.23
0.20
1.2
1.1
1.53
1.55
g/l
—
6
43
15
127
1.19
0.20
2.3
1.3
—
—
—
0
0
30
271
1.12
0.18
2.4
2.9
4.09
4.48
kpa
0.61
30
258
31
281
1.11
0.18
1.8
2.0
—
—
—
0
0
7
60
1.17
0.18
1.4
3.8
4.49
9.30
pmol/l
—
7
60
8
71
1.13
0.16
1.5
1.5
—
—
—
0
0
96
920
1.06
0.16
4.2
4.6
23.65
21.01
%
0.70
42
427
10
83
1.21
0.15
1.1
1.2
1.10
1.24
g/l
—
10
77
10
83
1.21
0.15
1.6
1.5
—
—
—
0
0
35
328
1.07
0.11
3.5
3.5
—
—
—
0
0
13
146
0.89
0.10
3.3
3.1
25.86
25.09
mmol/l
0.32
13
140
5
44
1.14
0.10
1.0
1.3
8.10
7.55
mmol/l
—
5
35
5
45
1.11
0.10
1.8
1.6
—
—
—
0
0
7
66
1.06
0.08
1.0
1.3
—
—
—
0
0
22
205
1.08
0.08
1.4
1.2
199.78
162.65
u/ml
—
9
85
8
76
1.05
0.07
1.6
1.2
—
—
—
0
0
8
77
1.04
0.07
1.6
1.2
—
—
—
0
0
31
324
0.95
0.05
2.7
3.5
5.85
5.73
kpa
0.31
31
311
26
250
1.04
0.03
1.8
2.0
—
—
—
0
0
66
650
1.02
0.02
2.6
2.9
2.45
2.45
mmol/l
0.02
58
586
11
111
0.99
0.00
1.3
1.1
1.39
1.59
g/l
1.30
11
111
37
369
1.00
0.00
1.6
1.9
1.66
1.51
%
0.50
28
326
10
95
1.05
0.00
1.6
1.5
—
—
—
0
0
10
96
1.04
0.00
1.6
1.6
—
—
—
0
0
11
114
0.96
0.00
1.3
1.2
0.88
0.92
g/l
0.29
11
114
17
166
1.03
0.00
3.9
3.7
35.58
49.56
%
1.32
17
159
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
7.41
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.84
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.2
—
9.87
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.1
—
32.71
—
0
7
0
9
0.00
-0.00
0.0
1.4
—
12.80
—
0
9
6
63
0.95
-0.00
1.3
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
1.22
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.2
—
4.47
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_BURSITISOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_BURSITISOTH | 1.001 [0.75, 1.33] | 0.996 |
| Birth year | 0.994 [0.99, 1.0] | 0.137 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 679 females with M13_BURSITISOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_BURSITISOTH | 0.81 [0.61, 1.07] | 0.136 |
| Birth year | 0.99 [0.98, 1.0] | 0.037 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 570 males with M13_BURSITISOTH died.
Mortality risk
Mortality risk for people of age
years, who have M13_BURSITISOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.111% | 0.188% |
| 5 | 0.535% | 1.046% |
| 10 | 1.395% | 2.788% |
| 15 | 2.757% | 5.075% |
| 20 | 4.987% | 8.741% |
Relationships between endpoints
↥Index endpoint: M13_BURSITISOTH – Other bursitis, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data